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Acetate relaxation of isolated vascular smooth muscle. The vasorelax-
ant effects of acetate in arginine vasopressin (AVP)-contracted rat tail
artery strips were examined in order to study mechanism of action.
Dose—dependent relaxation by acetate was found in the clinically
important range of 4 to 16 m. Relaxation was not due to complexing
of ionized calcium, persisted after mechanical removal of the endothe-
hum, and was not altered by pretreatment with indomethacin. Although
acetate also inhibited contraction by alpha-i and alpha-2 agonists, the
relaxant effect was not altered by destruction of sympathetic nerve
terminals using 6-hydroxydopamine. The degree of relaxation in this
model by various anions correlated with their lyotropic properties;
however, the vasorelaxant effect of acetate exceeded that which would
be expected on the basis of its position in the lyotropic series. The
vasorelaxant effect of acetate was shared by other short-chain fatty
acids that can be conjugated with coenzyme A (C0A), such as propio-
nate and malonate. In contrast, a much lesser or absent relaxant effect
was found with nonfatty—acid precursors of acetyl CoA, such as
pyruvate, lactate, and alanine. The vasorelaxant effect of acetate was
abolished by pretreatment with DIDS, an inhibitor of organic anion
uptake, suggesting that cellular uptake of acetate is essential to its
vasorelaxant action. The results suggest that the relaxant effect of
acetate in vascular smooth muscle is non-specific, is not mediated by
prostaglandins, does not depend upon the presence of either endothe-
hum or the sympathetic nervous system, and may be due to metabolism
of acetate to acetyl CoA with attendant conversion of ATP to AMP.
Acetate is commonly used in hemodialysis as a bicarbon-
ate—generating base. However, patients sometimes become
hypotensive when dialyzed against an acetate buffered dialysate
[1]. Although acetate has long been known to be a vasodilator
[2—6] little is known about the mechanism of its action. In
preliminary studies [7, 8], we established that helical strips of
the rat caudal artery contracted with potassium chloride (K),
phenylephrine, or arginine vasopressin (AVP) could all be
relaxed by acetate, with the greatest amount of relaxation being
evident in strips contracted with AVP. The objective of the
present experiments was to examine the vasorelaxant abilities
of acetate under various conditions in an attempt to further
delineate its mechanism of action.
Methods
Preparation of tissues
Studies were performed in caudal arteries taken from male
Sprague—Dawley rats weighing between 300 and 500 g. Each rat
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was killed by cervical dislocation. The tail of the rat was then
submerged in modified Krebs—Henseleit (KH) solution contain-
ing, in mM: Na 140; K 5.0; HCO3 25; Cl 124; Mg 0.8; Ca 1.35;
and dextrose 11. The KH solution was gassed with 95% oxygen
and 5% carbon dioxide. The tail artery was carefully removed
and cut into helical strips of 1.0 to 1.5 cm in length. Dissection
and cleaning of the artery and cutting of the strips were
performed at room temperature. The strips were then sus-
pended in warmed (37°C) KH solution and equilibrated under a
resting tension of 0.7 g for two hours. The KH solution in the
bath was changed every 15 minutes. After the two—hour equil-
ibration period, at 30 minute intervals, the strip was repeatedly
contracted by three minute exposure to 100 mi KCI (added
from a 4.0 M stock solution). Once the peak phasic contraction
to KC1 had stabilized, the strip was considered ready for study.
Experimental design
Acetate inhibition of A VP-induced contraction. Dose—
response curves to AVP were performed in the presence and
absence of acetate. Six strips from each rat (N = 11) were
randomized into six groups: control, 4 m acetate, 16 mM
acetate, 16 m acetate in which the concentration of CaCI2 was
increased by 5%, 16 m acetate in which the concentrations of
both CaCI2 and MgCI2 were increased by 5%, and 64 mM
acetate. The solutions with additional calcium were prepared to
counter the fact that, in a 16 m acetate solution, approxi-
mately 5% of the ionized calcium will be complexed [8]. The
amount of magnesium complexing by acetate is unknown, but
was presumed to be of similar magnitude. In previous studies,
we showed that acute reductions in either bath calcium or bath
magnesium concentration will cause relaxation in AVP-contract-
ed rat tail artery strips [7].
For each of the acetate groups, a modified KH solution was
prepared in which the desired amount of sodium acetate was
substituted for an identical amount of sodium chloride. Hence,
the sodium level of all the solutions used was identical. Simi-
larly, the bicarbonate concentration in all baths used remained
at 25 mM.
Strips assigned to the acetate groups were exposed to the
acetate containing solution for 15 minutes prior to performing
the AVP dose—response curve. AVP was added in a cumulative
fashion from appropriately—diluted stock solutions. Only one
dose—response curve was performed per strip. For each strip,
the contractions induced by each dose of AVP were normalized
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to the peak phasic contraction to 100 mM K, the latter having
been measured during the preconditioning procedure.
Acetate relaxation of A VP-contracted strips. Six strips from
each rat (N = 7) were randomized into six groups as above. The
strips, while in KH solution, were contracted by addition of 2 x
lO M AVP to the bath. After approximately five minutes,
when the contraction had peaked, the KH bath containing AVP
was isothermically replaced with a second bath containing the
same concentration of AVP but modified in composition to
include 0, 4, 16, or 64 m acetate. Again, three 16 m acetate
solutions with varying amounts of calcium and magnesium were
used, to give a total of six groups as described above. The
percent relaxation of each strip (in terms of the peak AVP
contraction) after five minutes of exposure to acetate was the
dependent variable.
Effect of position along the tail artery. All strips used in the
present studies were taken from the mid-portion of the tail.
Because the effect of hydralazine, for example, has been shown
to vary with position along the tail artery [9], experiments were
done comparing the relaxant effect of 16 m acetate (substi-
tuted for chloride) on AVP-contracted (2 X io— M) strips taken
from different positions along the mid-tail. Six 1.5 cm strips
were cut from the mid-tail of each rate (N 7). Each strip was
contracted with AVP in KH solution and relaxed with acetate,
as above. Relaxation was compared among the strips as a
function of their position along the tail.
Effect of endothelium removal. Six strips from each rat (N =
15) were randomly assigned to two groups, a control group and
an endothelium removed group. In the latter, the endothelium
was removed by gentle rubbing with a cotton tipped applicator
at time of initial preparation. In each group, strips were
contracted with AVP (2 x iO M), and then exposed to 0, 4, or
16 m acetate. The dependent variable was percent relaxation
after five minutes exposure to acetate in control versus
endothelium—denuded tissue. After each experiment was com-
pleted, the completeness of endothelium removal was assessed
by contracting the strip with AVP a second time, and assessing
the relaxant effect of acetyicholine (10—v through l0— M).
Because ACh is an endothelium dependent vasodilator, the
peak relaxation to ACh was used as an indicator of the presence
of functioning endothelium.
Effect of indomethacin. Six strips from each rat (N = 7) were
randomized into two groups, a control, and an indomethacin
treated, and then into three subgroups (0, 4, or 16 m acetate).
In those strips randomized into the indomethacin group, indo-
methacin l0— M was introduced into the bath after equilibra-
tion. Fifteen minutes later, in the continued presence of indo-
methacin, an AVP contraction was initiated. At the peak of the
contraction, the substitution solution containing indomethacin,
AVP and 0, 4, or 16 m acetate was instilled. The percent
relaxation at each level of acetate was determined and com-
pared to control experiments performed in identical fashion but
in the absence of indomethacin.
Effect of chemical sympathectomy. Six strips from each rat
(N = 10) were randomized into two groups: a control and a
sympathectomized. Sympathectomized strips were exposed
thrice (7 minutes each time) to a solution containing 6-
hydroxydopamine, phentolamine, and glutathione (0.065 mM),
according to a method modified from that described by
Aprigliano and Hermsmeyer 1101. The latter solution was not
oxygenated to minimize oxidative tissue damage. The control
strips were exposed for an identical length of time to a modified
solution from which 6-hydroxydopamine, the active agent, had
been omitted, Each strip was contracted with AVP (2 x l0—
M), and then exposed to a relaxation solution containing AVP
and 0, 4, or 16 m acetate, depending upon subgroup assign-
ment. The dependent variable was percent relaxation five
minutes after exposure to acetate in control versus sympathec-
tomized tissue. After each study, adequacy of sympathectomy
was assessed by performing a dose—response curve to tyramine.
Effect of DIDS. The design was identical to that for indo-
methacin, except that 1 mi DIDS (4,4'-disothiocyanato-
stilbene-2,2'-disulfonic acid), a compound that has been shown
to block cell uptake of anions [11, 121, was the additive. DIDS
addition was begun simultaneously with the addition of AVP.
Each group was made up of strips from eight rats.
Acetate effect on dose—response curves to methoxamine and
BHT-920. This was the only group of studies in which AVP was
not the contracting agent. The purpose was to determine the
ability of acetate to inhibit contractions induced by alpha-I and
alpha-2 agonists. Pilot studies showed that several sequential
dose—response curves to either of these compounds could be
obtained in the same strip without tachyphylaxis. Two strips
were taken from each rat (N = 9) and randomized into either a
methoxamine or a BHT-920 group. Two complete dose—re-
sponse curves to either methoxamine or BHT-920 (depending
upon group assignment) were performed in each strip. How-
ever, either the first or the second of the dose—response curves
was performed in the presence of 16 m acetate substituted for
chloride (the order of the dose—response curves with and
without acetate was balanced and randomized). When acetate
was used, exposure to acetate was begun 15 minutes prior to
starting the dose—response curve.
The data were analyzed using a curve fitting program [13]
which estimated values for agonist ED5O and peak contraction
to the agonist. The effect of acetate was expressed as the ratio
of agonist ED5O in the presence of acetate to agonist ED5O in
the absence of acetate (ED5O dose ratio). The relative potency
of acetate against BHT-920 and methoxamine contractions was
assessed by comparing the ED5O dose ratios using 16 mM
acetate for each of the two agonists.
Vasorelaxant effect of lyotropic anions. The lyotropic effects
of anions are related to their ability to salt out albumin and other
proteins from solution 114]. Twelve anions were studied, each
in the form of its sodium salt: fluoride, iodate, tartrate, sulfate,
(disodium) phosphate, bicarbonate, acetate, bromate, chloride,
nitrate, bromide, and thiocyanate. Nine pairs of rats were
studied. Twelve strips from each pair were randomly assigned
to one of these twelve anion groups. A given strip was first
contracted with AVP and then exposed to the anion. In these
experiments, the anion in question was added to the bath from
a concentrated (1 M) stock solution, and not substituted for
chloride as described above. The amount added was such that
the final calculated bath concentration of the anion would be 16
mM.
Lyotropic numbers for each anion were obtained from the
literature [14, 15], and the percent relaxation five minutes after
exposure to a given anion was plotted as a function of the
lyotropic number of the anion.
Vasorelaxant effect of compounds of intermediary metabo-
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lism. The design was similar to that for lyotropic anions. Eight
compounds were studied: L-alanine, pyruvate, DL-lactate,
chloride (control), acetate, propionate, malonate, and acetoace-
tate. Nine pairs of rats were studied. Eight strips from each pair
were randomly assigned to the eight compound groups. Each
strip was contracted with AVP and then exposed to the com-
pound in question. The compounds were added from 1 M stock
solutions, in an amount to result in a final bath concentration of
16 mi. In these studies, as in the lyotropic experiments, the
bath osmolality was allowed to increase. All compounds were
added in the form of sodium salts, with the exceptions of
acetoacetate, which was obtainable only as the lithium salt, and
alanine.
Vasorelaxant effects of adenosine and AMP in this model.
Because the effects of acetate could conceivably be secondary
to metabolic generation of AMP and possibly adenosine, the
vascular effects of the latter two compounds were also explored
in this model. Strips were randomized into one of three groups:
control, adenosine (10—s M), or AMP (lO- NI). Each strip was
contracted with AVP (2 X i0 M), and then exposed to a
relaxation solution containing AVP in KH and also containing
nothing (control), adenosine, or AMP. The dependent variable
was the percent relaxation after five minutes of exposure to the
adenine compound.
Studies of pH and ionized calcium
Solutions containing 25 m bicarbonate and one of each of
the lyotropic anions studied (16 mM) were prepared and gassed
with 95% oxygen and 5% carbon dioxide to maintain the PCO2
close to 40 mm Hg. A sample of each solution was then drawn
up into a sealed syringe and its pH measured using a blood gas
analyzer. The ionized calcium level was also measured using a
NovaTM calcium—selective electrode.
Preparation of agonists
All agonists were freshly prepared on the day of use. Potas-
sium chloride was dissolved in 0.9% NaC1 to make a 4 Nt stock
solution. Synthetic arginine vasopressin (Bachem, Torrance,
California, USA) was first dissolved in 0.9% NaC1 (100 mg/liter)
also containing 0.1% radioimmunoassay grade, bovine serum
albumin (Sigma). Small (0.1 ml) aliquots were frozen at —80°C
until the day of use. On the day of the experiment, an aliquot
was further diluted to the desired concentration in 0.9% NaC1
containing 0.1% radioimmunoassay grade, bovine serum albu-
min. Methoxamine powder (obtained as a courtesy of Bur-
roughs Wellcome Co., Research Triangle Park, North Carolina,
USA) and BHT-920 (Boehringer Ingelheim Ltd., Ridgefield,
Connecticut, USA) were dissolved in 0.9% NaCI containing
0.1% radioimmunoassay grade, bovine serum albumin. Indo-
methacin was dissolved in an aqueous stock solution after first
alkalinizing it with sodium carbonate as described by Spokas et
al[ 16]. DIDS and all other compounds were purchased from
Sigma Chemical Co. (St. Louis, Missouri, USA). All solutions
were otherwise made up from reagent grade chemicals dis-
solved in distilled water.
Statistical analysis
All values are reported as mean 1 SEM. In each study, the
significance of an overall treatment effect was first assessed
using ANOVA. If a significant (P < 0.05) F-ratio was obtained,
10 9 8 7 6
AVP
— log10 M
Fig. 1. Inhibition of contraction induced by cumulative addition of
AVP by exposure to 4, 16, or64 mM acetate. Symbols are: (0) control;
(•) 4 m acetate; (D) 16 m acetate (data from 3 groups with different
calcium and magnesium levels have been pooled); and () 64 mM
acetate.
the significance of differences among group means was further
explored using the Tukey B procedure [171. In the BHT-920 and
methoxamine studies, when ED5O values were obtained from
the curve fitting program used [13], a log transformation was
done on the ED5O values. The means and standard deviations of
ED5O values were calculated from the log transformed num-
bers, and then reconverted to their anti-logarithms.
Results
Dose—dependent inhibitory effect of acetate on AVP
contraction
The inhibitory effect of acetate on AVP contraction is de-
picted in Figure 1. As shown, the AVP contraction curve was
shifted to the right in a dose—dependent manner from 4 to 64
mM. ANOVA revealed a significant overall acetate effect at
only the three lowest AVP dose levels: 0.3 x l0— M, F = 2.83,
P = 0.05; 1 >< l0- M, F = 5.01, P = 0.003; 3 X iO M, F =
3.13, P = 0.03. A trend in the data did suggest that acetate also
diminished the peak AVP response.
In these studies, the maximum phasic contraction to 100 mM
KCI (administered during the conditioning phase) was 1240
43 (siM) mg. There was no difference in the phasic contraction
to KC1 among the six study groups (F = 0.25).
Dose—dependent relaxation of AVP constricted strips
In Figure 2, the relaxant effect of acetate against AVP
contraction is shown. Relaxation with 4 m acetate was signif-
icantly different from control (P < 0.05), and relaxation with 16
m acetate was significantly greater than with 4 m (P < 0.05).
Relaxation was not different among the subgroups exposed to
the three 16 m acetate solutions, two of which contained
supplemental calcium and/or magnesium. The amount of relax-
ation with 64 m acetate was not significantly greater than that
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Acetate, mM
Fig. 2. Relaxation of A VP-contracted strips induced by 4, 16, or 64mM
acetate. Symbols are: (•) baths unadjusted for calcium complexing;
() bath with 5.0% added calcium; and (U) bath with 5.0% added
calcium and 5.0% added magnesium.
In these studies the peak phasic contraction to KCI averaged
1098 40 mg, and was similar among the six groups (F =0.40,
P NS).
Effect of position along the tail artery on acetate relaxation.
The percent relaxation five minutes after exposure to 16 mivt
acetate averaged 31% 1.6 (sEM) for the six groups of strips
combined. As one proceeded along the mid-tail from the most
proximal to the most distal group, the relaxation percentages
were 30, 33, 37, 31, 30, and 28, respectively. These vaues were
not significantly different (F = 0.45, P NS). The peak phasic
contractions to KCI in these studies averaged 1176 4.9 mg,
and were not different among the segments.
Effect of endothelial rubbing on acetate relaxation.
Endothelial rubbing had no effect on the magnitude of acetate
induced relaxation. When endothelium was present, the spon-
taneous (control) relaxation of 10% 4.5 (sEM) was increased
to 37% 5.6 or to 64% 5.0 in the presence of 4 or 16 mM
acetate, respectively. When endothelium was absent, the spon-
taneous relaxation of 0% 1.6 was similarly increased to 30%
4.5 or 53% 3.8 in the presence of acetate. The values
obtained with rubbed strips and unrubbed strips were not
significantly different.
The peak phasic contraction to KC1 in these studies averaged
950 23 (sEM) mg, and was similar in the rubbed and unrubbed
strips. The peak relaxation to ACh in the rubbed strips (2.0%
1.6) was significantly less than in the unrubbed tissue (44%
4.5, P <0.001).
Effect of indomethacin on acetate relaxation. Incubation in
indomethacin had no effect on acetate induced relaxation. In
control strips, relaxation at five minutes in the presence of 0, 4,
or 16 m acetate averaged 19, 25, or 47%, respectively. In the
indomethacin incubated strips, the respective relaxation per-
centages were 16, 36, and 38. There was no significant indo-
methacin effect at any of these acetate levels.
The peak phasic contraction to KC1 in these studies averaged
Acetate, mM
Fig. 3. Effect of DIDS on the relaxant effect of acetate. Symbols are:(•) control studies; and (D) studies in the presence of 1O M DIDS.
850 85 mg. The response averaged 790 mg in the control
strips, and 934 in the indomethacin treated strips (P NS). The
magnitude of the AVP contraction tended (P NS) to be higher in
the indomethacin treated strips, averaging 81% 7.5 of the
peak phasic contraction to K, versus 69% 6.5 in controls.
Effect of chemical sympathectomy on acetate relaxation.
Chemical sympathectomy had no significant effect on the mag-
nitude of acetate induced relaxation. In control strips, the
percent relaxation at five minutes in the presence of 0, 4, or 16
m acetate averaged 9.3% 2.4, 34% 3.0, and 49% 3.1,
respectively. In denervated strips, the respective relaxation
percentages were: 8.1% 2.1, 37% 2.9, and 54% 1.4.
The peak phasic contraction to KCI in the control strips was
1029 60 mg; significantly higher than in the denervated strips
(775 37 mg, P <0.001). In control strips, the peak contraction
to tyramine averaged 819 72 mg; significantly greater than in
denervated strips (82 16 mg, P < 0.001).
Modulating effect of DIDS on acetate relaxation. Results are
shown in Figure 3. In the DIDS group, in the absence of
acetate, there was a slight, transient contraction just after
changing the bath at the peak of the AVP contraction. How-
ever, by five minutes, the relaxation (relative to the tension at
time of bath change) was similar in the control (4.0%) and DIDS
(—3.4%) groups (P NS). In the control group, relaxation in the
presence of 16 or 64 m acetate averaged 35% or 47%,
respectively. In the DIDS group, however, a large contraction
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Fig. 4. Vasorelaxant effect of different baths containing 16 m'c con-
centrations of various anions as a function of their lyotropic numbers.
The regression line calculated by least squares is shown (r =
—0.65, P
< 0.001). Abbreviations are: F, fluoride; 103, iodate; SO4, sulfate;
HPO4, disodium phosphate; HCO3, bicarbonate; Br03 bromate; Cl,
chloride; Br, bromide; NO3, nitrate; CNS, thiocyanate.
The tension levels at live minutes in the control versus DIDS
groups were highly significantly different at both levels of
acetate (P < 0.001).
The peak KC1 contractions in these studies averaged 1400 mg
89, and were not significantly different between the DIDS and
control groups.
Dose-response curves to methoxamine and BHT-920
In the control KH solution, the peak contraction to methox-
amine averaged 1478 128 (sEM) mg, whereas the peak
contraction to BHT-920 (in other strips) was less (735 56 mg,
P < 0.001). In the presence of acetate, the peak contraction to
either of these agonists was not significantly reduced. In the
control bath, the ED5O of methoxamine was 8.0 + 1.51—1.0 x
l0 M), a value that was significantly increased in the presence
of 16 m acetate (1.5 + 1.51—1.0 x l06i, P < 0.01). The
ED5O of BHT-920 in the control bath was 4.4 + 1.81—1.2 x l0
M). Acetate also shifted the ED5O of BHT-920 to the right (P <
0.01), to 2.24 + 1.23/—0.66 x 10—6 M). The ED5O dose ratio
(ED5O with acetate/ED5O without acetate) was greater for
BHT-920 (6.7 1.5) than for methoxamine (2.1 0.29, P <
0.05).
Vasorelaxant effect of the lyotropic anions
Results are shown in Figure 4. As can be seen, the lyotropic
anions, added to give a final bath concentration of 16 m, had
a vasorelaxant effect that was in proportion to their lyotropic
number. The overall correlation coefficient for this relationship
was —0.68, P < 0.01. The regression line calculated by least
squares is shown in the figure.
The percent relaxation with 16 m acetate in these studies, in
which acetate was added from a concentrated stock solution,
averaged 66 6.1, a value considerably greater than that
observed in the experiments in which acetate was substituted
for chloride (Fig. 2). The peak KCI contractions in these studies
averaged 1300 mg, and were not significantly different among
the 12 groups by ANOVA (F = 0.39).
Vasore/axant effect of fatty acid fragments and Krebs
intermediates
Results are depicted in Figure 5. As shown, the short—chain
fatty acids malonate and propionate were also quite efficacious
vasorelaxant agents, whereas acetoacetate was not. Relax-
ations obtained with acetate, propionate, and malonate were
not significantly different, but were significantly greater (P <
0.05 or less) than those obtained with all other agents. Pyruvate
and lactate appeared to be weak vasodilators, although their
relaxant ability compared to sodium chloride (controls) did not
quite attain statistical significance. Relaxations with sodium
chloride, alanine, and acetoacetate were not significantly dif-
ferent, although there was a trend for alanine to be associated
with a slight vasoconstriction.
Because acetoacetate could only be obtained commercially
as the lithium salt, several further experiments were done in
which the control bath contained 16 m lithium chloride, and in
which lithium acetoacetate was isosmotically substituted for
lithium chloride during the contraction. These studies con-
firmed the lack of vasorelaxant effect of acetoacetate in this
model.
Vasorelaxant effect of adenosine and AMP
Both adenosine and AMP, when applied at the peak of the
AVP induced contraction, caused transient increases in ten-
sion, peaking at one minute (adenosine: +37% 4.2, AMP:
+34% 3.7). However, after live minutes, tension in the
continued presence of adenosine (—4.8% 4.5 relative to
tension at time of solution substitution) was no different from
that in controls (—6.0% 3.4, P NS). With AMP, however, the
tension after five minutes (—28% 6.2) was less than in
controls (—2.0% 4.5, P < 0.05), indicating a relaxant property











































Fig. 5. Effect of various compounds of intermediary metabolism on
A VP-induced contraction.
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Studies of pH and ionized calcium values
Solutions containing acetate. Isotonic or hyperosmotic solu-
tions containing 0, 4, 16, or 64 m acetate and also containing
25 m bicarbonate did not differ with respect to pH. When the
PCO2 was kept at 40 mm Hg, the pH of all these solutions was
very close to 7,38, The ionized calcium values, as measured by
the Nova calcium—selective electrode, did decrease slightly, by
2.2, 5.1, and 24%, respectively, for solutions containing 4, 16,
and 64 m acetate, as demonstrated by us earlier [81.
Solujions containing other lyotropic anions. In solutions
containing 25 m bicarbonate and 16 m of each of the other
lyotropic anions, the pH was also very close to 7.38 when the
PCO2 was kept at 40 mm Hg. The only exception was when an
additional 16 m of sodium bicarbonate was added, in which
case the pH shifted to 7.45. The electrode—determined ionized
calcium values for the various ion solutions (as percent of
control) were: fluoride—out of range, iodate—89%, tartrate—
62%, sulfate—77%, phosphate—out of range, bicarbonate—
83%, acetate—94%, bromate—97%, chloride—l00%, nitrate—
98%, bromide—99%, and thiocyanate—69%. There was no
correlation between complexing of calcium as measured by the
electrode and the degree of vasorelaxation.
Discussion
Our results suggest that acetate has a marked relaxant effect
on isolated vascular smooth—muscle. The vasorelaxant effect is
dose—related and is demonstrable at levels which are commonly
achieved in the plasma during dialysis [18]. Our results thus
extend and confirm previous reports of the vasodilating effect of
acetate in a number of animal models [2—8].
In previous studies we showed that acetate relaxes rat tail
artery strips constricted with a variety of different agonists,
including potassium chloride (KCI), phenylephrine, and argi-
nine vasopressin (AVP) [7, 8]. In the present study, we also
found that acetate inhibits contraction by methoxamine (an
alpha-i agonist), and by BHT-920 (an alpha-2 agonist). Taken
together, the findings suggest that acetate relaxes smooth
muscle by a non-specific mechanism. The effect of acetate
against alpha-2 induced contraction in our studies was greater
than against alpha-l mediated contraction. Van Zwieten, van
Mccl and Timmermans have suggested that preferential inhibi-
tion of alpha-2 versus alpha- 1 generated tension is a property
shared by the calcium entry blockers [19]. Accordingly, prefer-
ential inhibition of alpha-2 contraction by acetate might be
interpreted as evidence that acetate may be acting as a calcium
uptake blocker, However, acetate is a very weak inhibitor of
contractions induced by KC1 (Daugirdas, unpublished informa-
tion), suggesting that calcium entry blockade is not a primary
mechanism of action. Furthermore, the preferential inhibition
of alpha-2 contractions by acetate can also be explained on the
basis of receptor occupancy theory: in addition to calcium
channel blockers, many other vasodilators, including hydral-
azine and sodium nitroprusside, have been shown to inhibit
alpha-2 contractions more than alpha-l contractions [20]. The
postulated mechanism relates to the fact that the weaker
alpha-2 agonist requires a greater proportion of cell surface
receptors to be occupied to obtain an equivalent degree of
contraction, and hence is especially susceptible to the action of
vasodilators.
The rat tail artery is a richly innervated blood vessel, and it
has been shown that K-generated tension in this tissue is
partially dependent upon norepinephrine release [21]. In a
conscious dog model, we have shown that chemically sympa-
thectomized animals develop severe (albeit transient) hypoten-
sion when exposed to an acetate buffered dialysate [6]. Thus,
some of the effects of acetate in our model might conceivably
have been due to acetate induced suppression of norepineph-
rine release in the wall of the vessel strip. However, in the
present experiments, acetate was equally potent in relaxing
control and chemically sympathectomized tissue, suggesting
that the relaxant effect of acetate is not mediated by inhibition
of the sympathetic nervous system. Of note, the effect of
hydralazine, another "non-specific" vasodilator, can be en-
hanced in the proximal tail artery by prior chemical
sympathectomy [9]. Our results do not rule out a separate effect
of acetate on sympathetic nerve transmission, however.
Having established that acetate relaxes the tail artery by a
direct, non-specific action, the possibility remained that the
action of acetate might be mediated by the endothelium or by
prostaglandin synthesis. Our findings do not support this pos-
sibility, as the amount of relaxation in vessel strips from which
the endothelium had been removed and in vessel strips treated
with indomethacin was similar to that in control tissues.
Acetate, as well as other anions, share, to a greater or lesser
extent, what have been described as lyotropic properties,
defined as the ability to "salt out" proteins, for example,
albumin, from solution 114]. The lyotropic properties of anions
have been shown to correlate very well with a number of other
superficially unrelated attributes, such as the ability to differ-
entially congregate at air—fluid interfaces, and the ability to
affect the electrical properties of transmission across the cell
membrane [151. In fact, acetate is known to hyperpolarize
certain cell membranes [22, 23]. Thus, it is conceivable that
acetate and other lyotropic anions relax vascular smooth mus-
cle via effects on either the resting transmembrane potential, or
on ion conductance through the membrane. Our model permit-
ted only a crude test of such a hypothesis. Although the
lyotropic ability of the anions studied did correlate with their
ability to relax AVP-induced contractions, the effect of acetate
appeared to be greater than that which would have been
expected based on the position of acetate in the lyotropic series.
DIDS is an agent that may block cell uptake of many anions
[ii, 121. DIDS does not affect the action of certain vasodilators
believed to act at the cell membrane, such as ouabain [121.
DIDS may thus be a tool for evaluating the importance of
cellular uptake of an anion to its mechanism of action. DIDS
completely blocked the vasorelaxant effect of acetate in our
model. This finding suggests that cellular penetration of acetate
is important to its mode of action.
If cellular uptake of acetate is indeed necessary for it to relax
vascular smooth muscle, it is conceivable that acetate induces
relaxation via formation of intermediary metabolites. Such a
"metabolic" hypothesis of acetate action was first advocated
by Liang and Lowenstein [24]. During acetate infusion, these
investigators found elevated muscle levels of adenosine
monophosphate (AMP) and increased cardiac levels of adeno-
sine. They hypothesized that conjugation of acetate with coen-
zyme A in the mitochondria to form acetyl CoA, a reaction that
consumes ATP [25], resulted in increased tissue levels of both
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AMP and adenosine. The potential clinical importance of this
mechanism was recently highlighted by the demonstration of
ATP depletion in circulating platelets during acetate buffered
hemodialysis [26]. How acute conversion of ATP to AMP by
acetate might cause vasorelaxation is completely unknown.
Many of the adenine nucleotides can act as vasodilators in
preconstricted vessel strips, possibly by virtue of their effect on
purinergic receptors [27]. The presence of the latter on the
presynaptic nerve terminal, on the postsynaptic smooth muscle
surface, and on the endothelium, is now well established [27].
Adenosine may also act at an intracellular site to cause
vasorelaxation [28]. Acute conversion of ATP to AMP might,
therefore, cause vasorelaxation by virtue of leakage of AMP out
of the cell and activation of a purinergic receptor. Adenosine
might also be generated from AMP via salvage pathways, and
the adenosine could act either intracellularly or outside of the
cell. Alternatively, acute changes in the ATP balance of the cell
might cause vasorelaxation by affecting intracellular cyclic
nucleotide levels, the intracellular calcium concentration, or the
inositol triphosphate and protein kinase C systems, all of which
have been implicated in vascular contraction/relaxation events.
In an attempt to indirectly validate the "metabolic" hypoth-
esis of acetate action, we assessed the vasorelaxant abilities of
a number of other compounds that can also feed into the Krebs
cycle. Propionate can be conjugated to propionyl CoA in a
reaction that consumes ATP [25]. The metabolic hypothesis
would predict that propionate, as well as the chemically similar
short—chain fatty acid derivatives malonate and acetoacetate,
should also have vasorelaxant effects. In fact, both propionate
and malonate evidenced strong vasorelaxant properties in our
model. The lack of vasodilatation with acetoacetate is interest-
ing, and might be explained by the fact that there exists an
enzyme which is capable of synthesizing the acetoacetate CoA
derivative by transferring CoA from succinate to acetoacetate,
in a reaction which does not involve the direct consumption of
ATP [29]. The finding that pyruvate, lactate and alanine were
not strong vasodilators in our model also supports the metabolic
hypothesis of acetate action. Like acetate, pyruvate, lactate,
and alanine are eventually metabolized to acetyl CoA. How-
ever, the reaction sequence for the last three compounds does
not result in direct consumption of ATP [25].
In further exploration of ramifications of the metabolic hy-
pothesis of acetate action, we looked for the ability of AMP and
adenosine to relax the AVP-contracted rat tail artery. Previous
investigators have reported that adenosine and AMP have little
effect on tension in this system [9], or have noted a vasocon-
strictive response [301. We found that AMP, but not adenosine,
did relax the AVP-constricted rat tail artery when added to the
tissue bath in a high concentration. We also identified a tran-
sient vasoconstrictive effect of both AMP and adenosine.
In conclusion, we have established a rat tail—artery model
wherein the mechanism of action of acetate can be pursued. All
data were consistent with the metabolic hypothesis of action of
acetate; namely, that acetate induced vasorelaxation is medi-
ated by cellular uptake of acetate with subsequent metabolism
to acetyl CoA and attendant conversion of ATP to AMP. The
intracellular links between acetate metabolism and vasorelaxa-
tion remain to be defined.
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